Co-Diagnostics, Inc. Common Stock (CODX NASDAQ) stock market data APIs
$1.6292
-0.04(-2.5%)
as of May 6, 2026
Try our APIs with
free plan!
Co-Diagnostics, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Prev. Close
1.6292
Open
1.5902
High
1.6299
Low
1.5406
52 wk Range
1.35-46.5
Market Cap
5 908 K
Shares Outstanding
3 602 K
Revenue
622 K
EPS
-4.4388
Beta
1.264
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Co-Diagnostics, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Co-Diagnostics, Inc. Common Stock data using free add-ons & libraries
Get Co-Diagnostics, Inc. Common Stock Fundamental Data
Co-Diagnostics, Inc. Common Stock Fundamental data includes:
- Net Revenue: 622 K
- EBITDA: -30 176 544
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Co-Diagnostics, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-19
- EPS/Forecast: -0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Co-Diagnostics, Inc. Common Stock News
New
Co-Diagnostics, Inc. Q4 2025 Earnings Call Summary
Co-Diagnostics, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Operational Context Management is prioritizing speed to market by removing COVID-19 from its initial upper respirato...
Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options
Earnings Call Insights: Co-Diagnostics (CODX) Q4 2025 MANAGEMENT VIEW * “We were pleased to successfully complete the appeal and have our shares relisted, and we are now firmly focused on moving...
Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more
[Nest of Eggs] LindaJoHeilman As the calendar turns from March to April, a holiday-shortened week still delivers a diverse set of earnings with the potential to offer fresh directional cues. Consume...
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity
Co-Diagnostics Inc. on Friday signed an agreement for CoSara Diagnostics Pvt. Ltd, to expand its commercial and distribution territory across South Asia to include Bangladesh, Pakistan, Nepal, and Sri...
Get Co-Diagnostics, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
